CN Patent

CN102906095A — 作为syk和jak抑制剂的吡咯并吡嗪衍生物

Assigned to F Hoffmann La Roche AG · Expires 2013-01-30 · 13y expired

What this patent protects

本发明涉及式I的新的吡咯并吡嗪衍生物的用途，其中变量Q和R 1 和R 2 如本文所述的定义，其抑制JAK和SYK并且对于治疗自身免疫疾病和炎性疾病有用。

USPTO Abstract

本发明涉及式I的新的吡咯并吡嗪衍生物的用途，其中变量Q和R 1 和R 2 如本文所述的定义，其抑制JAK和SYK并且对于治疗自身免疫疾病和炎性疾病有用。

Drugs covered by this patent

Patent Metadata

Patent number
CN102906095A
Jurisdiction
CN
Classification
—
Expires
2013-01-30
Drug substance claim
No
Drug product claim
No
Assignee
F Hoffmann La Roche AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.